Concordia Healthcare Corp. T.CXR.R

Drug Efficacy Study Implementation (DESI) program

[TheForces]

Donnatal, Concordia's #1 drug, because of its 800% price increase since it was bought, sold, resold between pharma companies, is under the FDA's DESI program.

This is a drug under attack and nobody will show any love to Concordia or owners (shareholders) if a generic is fact tracked or a substitute is pushed through by the FDA.

GIven the intense political scrutiny here, if I was head of the FDA, I would make it my mission to have a quick win against pharmas that price gouge patients in need.

Shareholders, you are holding a time bomb here.  Don't attack the messengers of bad news. Research the bad new to get familiar with the landscape.

This is truly a multidimentional "play" here.  You have Private Equity bouncing these drugs between each other, making deals, stock swaps, IOUs etc. 

Know what you own! 

"karma has everyone's address"

[LaticelnExile]

This post has been removed in accordance with Community Policy

[TheForces]

I stand corrected.  You are incredibly well researched!  I can understand paid supporters of Concordia going after you but shareholders should really read and research the information you have provided. And they should thank you and everyone else here providing facts instead of baseless opinions. I certainly would not want to be on the opposite side of the argument with you.  You

[argentia77]

Lattice, Actually it was Wayne Kreppner who explained the softness in Donnatal revenue to the sales force being taken out of the field for 2 weeks in his response to a question from Martin Landry GMP Securities) during the con call on March 24: Martin Landry Okay that's fair. And the next question on Donnatal, looking at the IMS data, it feels like the scripts have declined a little bit

[LaticelnExile]

This post has been removed in accordance with Community Policy